These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6169957)

  • 81. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
    Hanna W; Grell GA
    South Med J; 1980 May; 73(5):653-4. PubMed ID: 6103586
    [No Abstract]   [Full Text] [Related]  

  • 82. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Labetalol for hypertension.
    Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758
    [No Abstract]   [Full Text] [Related]  

  • 84. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 85. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M; Levarlet M; Lambilliotte JP; Lignian H; de Rood M
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):233-40. PubMed ID: 6673473
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension.
    Doyle AE
    Hypertension; 1983; 5(4 Pt 2):II103-8. PubMed ID: 6134671
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
    Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R; Kellaway GS
    N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Labetalol and renal function.
    Watson A; Maher K; Keogh JA
    Ir J Med Sci; 1981 Jun; 150(6):174-7. PubMed ID: 7275562
    [No Abstract]   [Full Text] [Related]  

  • 94. Labetalol and the management of hypertension.
    Reid JL; Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S60-8. PubMed ID: 6169961
    [No Abstract]   [Full Text] [Related]  

  • 95. Labetalol and bendrofluazide.
    Robinson IG; Allen B
    Med J Aust; 1979 Oct; 2(7):366. PubMed ID: 514192
    [No Abstract]   [Full Text] [Related]  

  • 96. Effects of labetalol on lipid and carbohydrates metabolism.
    Pagnan A; Pessina AC; Hlede M; Zanetti G; Dal Palu' C
    Pharmacol Res Commun; 1979 Mar; 11(3):227-36. PubMed ID: 223175
    [No Abstract]   [Full Text] [Related]  

  • 97. Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates.
    Devoto P; Stefanini E; Marchisio AM; Vernaleone F; Collu R
    Pharmacol Res Commun; 1980 Feb; 12(2):177-82. PubMed ID: 6104337
    [No Abstract]   [Full Text] [Related]  

  • 98. Labetolol in patients with hypertension and varying degrees of renal impairment.
    Breen EG; Lombard M; Watson A; Keogh JA
    Ir J Med Sci; 1984 Oct; 153(10):336-42. PubMed ID: 6511284
    [No Abstract]   [Full Text] [Related]  

  • 99. Beta-adrenergic blocking drugs in the treatment of hypertension.
    Scriven AJ; Lewis PJ
    Pharmacol Ther; 1983; 20(1):95-131. PubMed ID: 6137842
    [No Abstract]   [Full Text] [Related]  

  • 100. Multiple Bier blocks with labetalol for complex regional pain syndrome refractory to other treatments.
    Hord ED; Stojanovic MP; Vallejo R; Barna SA; Santiago-Palma J; Mao J
    J Pain Symptom Manage; 2003 Apr; 25(4):299-302. PubMed ID: 12691679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.